Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

227.72 +3.28 (+1.46%)
Official Closing Price Updated: 4:10 PM EST, Jan 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,961,298
Open 226.40
Bid (Size) 227.16 (100)
Ask (Size) 228.98 (200)
Prev. Close 224.44
Today's Range 226.07 - 228.57
52wk Range 141.50 - 225.50
Shares Outstanding 2,628,679,824
Dividend Yield 2.28%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Biological Singularity: How Nobel-Winning AlphaFold 3 is Rewriting the Blueprint of Life
In the annals of scientific history, few moments represent a clearer "before and after" than the arrival of AlphaFold 3. Developed by Google DeepMind and its dedicated drug-discovery arm, Isomorphic... 
Via TokenRing AI
Topics Artificial Intelligence Economy
News headline image
Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation
MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra... 
Via MarketMinute

Performance

YTD
+9.8%
+9.8%
1 Month
+9.7%
+9.7%
3 Month
+21.8%
+21.8%
6 Month
+35.5%
+35.5%
1 Year
+48.9%
+48.9%

More News

Read More
News headline image
Dividend Growers: 2 Stocks That Could Be Worth $1 Trillion in 7 Years ↗
Via The Motley Fool
Topics Credit Cards
News headline image
3 Dividend Stocks to Hold for the Next 20 Years ↗
Via The Motley Fool
News headline image
JNJ Stock Rises On Fresh FDA Approval For Multiple Myeloma Drug ↗
Via Stocktwits
News headline image
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants
Via MarketMinute
News headline image
The $100 Billion Milestone: Johnson & Johnson Pivots from 'Steady' 2025 to Growth-Focused 2026
Via MarketMinute
Topics Earnings Economy Government
News headline image
Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile
From Johnson & Johnson
Via Business Wire
News headline image
The Great Consolidation: US M&A Values Double as AI and Bio-Pharma Spark $2 Trillion Surge
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Johnson & Johnson At 52‑Week High: Momentum, Fundamentals And An Earnings Window ↗
Via Talk Markets
News headline image
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors ↗
Via MarketBeat
News headline image
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
Via The Motley Fool
Topics ETFs Intellectual Property World Trade
News headline image
Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
2 Soaring Stocks to Hold for the Next 20 Years ↗
Via The Motley Fool
Topics Intellectual Property World Trade
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Johnson & Johnson Quietly Triggers a Trend Following Buy Signal ↗
Via MarketBeat
News headline image
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Is This Dividend King a Screaming Buy? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026. ↗
Via The Motley Fool
Topics Stocks
News headline image
Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
Via MarketMinute
Topics Earnings Economy Intellectual Property
News headline image
Johnson & Johnson Analyst Raises Price Target On Several Tailwinds In 2026 ↗
Via Benzinga
The Davos Pivot: Trump’s Tariff U-Turn Sends Markets Into a Greenland Glow ↗
Via Chartmill
Topics Government
News headline image
This 2.4%-Yielding Dividend King Remains As Healthy As Ever ↗
Via The Motley Fool
Topics Bonds
News headline image
S&P 500 Jumps Over 1% As Trump Withdraws EU Tariff Threat: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗
Via Benzinga
Topics Government Stocks World Trade

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 227.72
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 01/28/26 04:10 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 598.60B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 599B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.